GPs Guide

Genetic testing in the Reproductive Health Journey

A quick comparison of early pregnancy, mid-pregnancy and pre-pregnancy screening options, outlining what each test detects and key timing or Medicare considerations.
Available tests
Genetic Carrier Screening
Alpha Thalassaemia
Generation™ NIPT
Generation™ 46 NIPT
Generation™ Plus NIPT
Fetal RhD Testing
Suitable for
Conditions Detected
Cystic Fibrosis, Spinal Muscular Atrophy, Fragile X syndrome
Alpha Thalassaemia
Non‑invasive prenatal screening (NIPT) for common genetic variants
Expanded genome‑wide NIPT for patients seeking broader genetic screening
NIPT for common genetic variants and microdeletions
Screening for fetal RhD status in RhD negative pregnancies
Pricing
Medicare rebatable*
Medicare rebatable*
$485**
$525**
$799**
Medicare rebatable*
Turnaround time
Visit our website for the current turnaround time
3 – 4 weeks
3 - 7 business days
3 - 7 business days
11 - 15 business days
7 - 10 business days
Collection day
Any day
Any day
Any day
Any day
Monday only (regional WA & NT Monday before 11am)
Any day
Genetic Counselling
Free post-test counselling for high-risk couples
Not required
Free post-test counselling for high-risk result
Free post-test counselling for high-risk result
Free post-test counselling for high-risk result
Not required
Suitable for:
PRE-PREGNANCY
EARLY PREGNANCY
(First trimester)
MID-PREGNANCY
(Second trimester)
*Testing is rebatable providing Medicare criteria are met.
**Pricing is correct as of April 2026.
Further information

Genetic Carrier Screening & Alpha Thalassaemia

EARLY PREGNANCY
PRE-PREGNANCY

What do they detect:

  • Genetic Carrier Screening:
    Cystic Fibrosis, Spinal Muscular Atrophy, and Fragile X syndrome carriers
  • Alpha Thalassaemia:
    Alpha Thalassaemia carriers

Important considerations:

  • RANZCOG recommends offering both tests to patients planning a pregnancy or currently pregnant.
  • Medicare covers male testing only when the female partner is identified as a carrier of CF or SMA.
  • Genomic Diagnostics now offers full gene sequencing on Cystic Fibrosis.

Generation™ NIPT Options

EARLY PREGNANCY
MID-PREGNANCY

What do they detect:

  • Generation™ NIPT:
    Common conditions (Downs, Edwards, Patau) and sex chromosome conditions
  • Generation™ 46 NIPT:
    Common and rare conditions across all 46 chromosomes including whole and partial chromosome deletions and duplications
  • Generation™ Plus NIPT:
    Common and selected microdeletion conditions (22q11, 15q11, 1q36, 4p and 5p)
  • Fetal Sex:
    Is optional and available for all Generation™ NIPT options.

Important considerations:

  • Can only be performed from 10 weeks’ gestation.

Fetal RhD Testing

EARLY PREGNANCY
MID-PREGNANCY

What do they detect:

  • Fetal RhD status in RhD negative pregnant women

Important considerations:

  • Recommended after 18 weeks’ gestation but can be performed from 11 weeks.
  • Negative fetal RhD results before 18 weeks are recommended to be retested after this time.

Genetic Counselling:

A free-of-charge telehealth counselling session is available for high‑risk results for GCS and GenerationTM NIPT. If the patient is eligible, this will be noted in the report under the Results. Please contact the Customer Care team to arrange an appointment for the patient.

How to get your patient tested
1

Patient Discussion

Discuss Genomic Diagnostics reproductive health products with your patient. Order the required tests using the appropriate test request form, noting any indication or relevant clinical details.

Test request forms are available via patient management software, online at genomicdiagnostics.com.au, or as hard‑copy pads.

2

Sample collection

Have your patient visit one of our collection centres to get their blood sample collected.

Payment, if required, is made online at genomicdiagnostics.com.au/tests or by phone on 1800 822 999.

3

Test results

Results are delivered to you by your preferred method. Genetic counselling is provided for patients with high‑risk Generation™ NIPT or GCS results.

Please discuss the results with your patient and advise if genetic counselling is required.